ZHU; Liusheng
Patent Applications and Registrations
Patent applications and USPTO patent grants for ZHU; Liusheng.The latest application filed is for "cd73 inhibitors".
Company Profile
16.26.40
- ZHU; Liusheng - Foster City CA
- ZHU; Liusheng - South San Francisco CA
- ZHU; Liusheng - Thousand Oaks CA
- Zhu; Liusheng - Burlingame CA
Patent Activity
| Patent | Date |
|---|---|
| Cd73 Inhibitors App 20220220147 - DU; Xiaohui ; et al. | 2022-07-14 |
| CD73 inhibitors Grant 11,325,938 - Du , et al. May 10, 2 | 2022-05-10 |
| Compounds that inhibit MCL-1 protein Grant 11,306,107 - Brown , et al. April 19, 2 | 2022-04-19 |
| Substituted Pyridine Derivatives As Sarm1 Inhibitors App 20220081417 - Brown; Sean Pomeroy ; et al. | 2022-03-17 |
| Glucocorticoid Receptor Modulators App 20220079924 - DU; Xiaohui ; et al. | 2022-03-17 |
| Inhibitors of glucocorticoid receptor Grant 11,208,432 - Sun , et al. December 28, 2 | 2021-12-28 |
| Inhibitors Of Glucocorticoid Receptor App 20210395295 - SUN; Daqing ; et al. | 2021-12-23 |
| Inhibitors Of Glucocorticoid Receptor App 20210379084 - SUN; Daqing ; et al. | 2021-12-09 |
| CD73 inhibitors Grant 11,130,778 - Du , et al. September 28, 2 | 2021-09-28 |
| Inhibitors of glucocorticoid receptor Grant 11,124,537 - Sun , et al. September 21, 2 | 2021-09-21 |
| Inhibitors of glucocorticoid receptor Grant 11,110,103 - Sun , et al. September 7, 2 | 2021-09-07 |
| Compounds That Inhibit Mcl-1 Protein App 20210230189 - BROWN; Sean P. ; et al. | 2021-07-29 |
| Cd73 Inhibitors App 20210214387 - DU; Xiaohui ; et al. | 2021-07-15 |
| CD73 inhibitors Grant 11,028,120 - Du , et al. June 8, 2 | 2021-06-08 |
| Cd73 Inhibitors App 20210130390 - DU; Xiaohui ; et al. | 2021-05-06 |
| Cd73 Inhibitors App 20210130389 - DU; Xiaohui ; et al. | 2021-05-06 |
| Glucocorticoid Receptor Modulators App 20210122730 - DU; Xiaohui ; et al. | 2021-04-29 |
| Cd73 Inhibitors App 20210047359 - Du; Xiaohui ; et al. | 2021-02-18 |
| Inhibitors Of Glucocorticoid Receptor App 20210023095 - SUN; Daqing ; et al. | 2021-01-28 |
| Inhibitors Of Glucocorticoid Receptor App 20210017219 - SUN; Daqing ; et al. | 2021-01-21 |
| Inhibitors Of Glucocorticoid Receptor App 20210017220 - SUN; Daqing ; et al. | 2021-01-21 |
| Inhibitors Of Glucocorticoid Receptor App 20210002324 - SUN; Daqing ; et al. | 2021-01-07 |
| Compounds that inhibit MCL-1 protein Grant 10,836,779 - Brown , et al. November 17, 2 | 2020-11-17 |
| Inhibitors of glucocorticoid receptor Grant 10,836,789 - Sun , et al. November 17, 2 | 2020-11-17 |
| Inhibitors Of Glucocorticoid Receptor App 20200291058 - SUN; Daqing ; et al. | 2020-09-17 |
| Inhibitors of glucocorticoid receptor Grant 10,723,759 - Sun , et al. | 2020-07-28 |
| Compounds That Inhibit Mcl-1 Protein App 20200062780 - BROWN; Sean P. ; et al. | 2020-02-27 |
| Inhibitors Of Glucocorticoid Receptor App 20200055892 - SUN; Daqing ; et al. | 2020-02-20 |
| Inhibitors of glucocorticoid receptor Grant 10,472,387 - Sun , et al. Nov | 2019-11-12 |
| Inhibitors Of Glucocorticoid Receptor App 20190218246 - SUN; Daqing ; et al. | 2019-07-18 |
| Compounds That Inhibit Mcl-1 Protein App 20190023720 - BROWN; Sean P. ; et al. | 2019-01-24 |
| Compounds That Inhibit Mcl-1 Protein App 20190016736 - BROWN; Sean P. ; et al. | 2019-01-17 |
| Compounds that inhibit Mcl-1 protein Grant 10,100,063 - Brown , et al. October 16, 2 | 2018-10-16 |
| Compounds That Inhibit Mcl-1 Protein App 20170088560 - BROWN; Sean P. ; et al. | 2017-03-30 |
| Compounds That Inhibit Mcl-1 Protein App 20160068545 - BROWN; Sean P. ; et al. | 2016-03-10 |
| Spirocyclic GPR40 modulators Grant 8,748,462 - Brown , et al. June 10, 2 | 2014-06-10 |
| Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders Grant 8,450,522 - Brown , et al. May 28, 2 | 2013-05-28 |
| Substituted biphenyl GPR40 modulators Grant 8,030,354 - Brown , et al. October 4, 2 | 2011-10-04 |
| Spirocyclic Gpr40 Modulators App 20110190330 - Brown; Sean P. ; et al. | 2011-08-04 |
| Conformationally Constrained Carboxylic Acid Derivatives Useful for Treating Metabolic Disorders App 20100298367 - Brown; Sean P. ; et al. | 2010-11-25 |
| Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders Grant 7,816,367 - Akerman , et al. October 19, 2 | 2010-10-19 |
| Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders Grant 7,649,110 - Akerman , et al. January 19, 2 | 2010-01-19 |
| Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders App 20090275598 - Akerman; Michelle ; et al. | 2009-11-05 |
| Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders Grant 7,582,803 - Akerman , et al. September 1, 2 | 2009-09-01 |
| Substituted biphenyl GPR40 modulators App 20090137561 - Brown; Sean P. ; et al. | 2009-05-28 |
| Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders Grant 7,465,804 - Houze , et al. December 16, 2 | 2008-12-16 |
| Bicyclic carboxylic acid derivatives useful for treating metabolic disorders App 20070244155 - Sharma; Rajiv ; et al. | 2007-10-18 |
| CXCR3 antagonists App 20070149557 - Collins; Tassie L. ; et al. | 2007-06-28 |
| Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders App 20070142384 - Akerman; Michelle ; et al. | 2007-06-21 |
| Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders App 20070066647 - Akerman; Michelle ; et al. | 2007-03-22 |
| CCR4 antagonists Grant 7,144,903 - Collins , et al. December 5, 2 | 2006-12-05 |
| Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders App 20060270724 - Houze; Jonathan ; et al. | 2006-11-30 |
| CXCR3 antagonists Grant 7,067,662 - Medina , et al. June 27, 2 | 2006-06-27 |
| Substituted Quinazolin-4(3H)-one compounds, compositions, and methods for their use Grant 7,053,215 - Medina , et al. May 30, 2 | 2006-05-30 |
| Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders App 20060004012 - Akerman; Michelle ; et al. | 2006-01-05 |
| STAT modulators App 20050101540 - Huang, Alan ; et al. | 2005-05-12 |
| STAT modulators Grant 6,884,782 - Huang , et al. April 26, 2 | 2005-04-26 |
| CXCR3 antagonists App 20050075333 - Medina, Julio C. ; et al. | 2005-04-07 |
| CXCR3 antagonists App 20030069234 - Medina, Julio C. ; et al. | 2003-04-10 |
| CXCR3 antagonists App 20030055054 - Medina, Julio C. ; et al. | 2003-03-20 |
| Ccr4 antagonists App 20030018022 - Collins, Tassie ; et al. | 2003-01-23 |
| CXCR3 antagonists App 20020169159 - Medina, Julio C. ; et al. | 2002-11-14 |
| STAT modulators App 20020151504 - Huang, Alan ; et al. | 2002-10-17 |
| LXR modulators Grant 6,316,503 - Li , et al. November 13, 2 | 2001-11-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 